Related Experiment Video
Updated: Jul 19, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
[The phenotype and function of CD4+ CD25+ regulatory T cells in hepatitis B patients]
Jun-liang Fu1, Dong-ping Xu, Ming Shi
1Research Center of Biological Therapy, the 302th Hospital of PLA, Beijing 100039, China.
Insights
Chronic hepatitis B patients have more regulatory T cells (Treg) than acute hepatitis B patients. These Treg cells can suppress hepatitis B virus (HBV) specific immune responses in vitro, offering insights into HBV immunopathogenesis.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Hepatitis B virus (HBV) infection can lead to chronic liver disease.
- Regulatory T cells (Treg) play a crucial role in immune homeostasis and tolerance.
- The specific role of Treg cells in the immunopathogenesis of HBV infection requires further elucidation.
Purpose of the Study:
- To investigate the frequency, phenotype, and function of CD4+ CD25 high regulatory T cells (Treg) in patients with acute hepatitis B (AHB) and chronic hepatitis B (CHB).
Main Methods:
- Flow cytometry was used to analyze Treg frequency and phenotype (CD45RO, CD45RA, CD95, HLA-DR) in peripheral blood mononuclear cells (PBMCs) from AHB, CHB patients, and healthy controls.
- Intracellular staining assessed cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) expression, while real-time RT-PCR detected Forkhead/winged helix transcription factor (FoxP3) mRNA.
- The suppressive function of purified Treg cells on PBMC proliferation and interferon-gamma (IFN-γ) secretion was evaluated using [3H]-thymidine incorporation assays and ELISA, respectively.
Main Results:
- Chronic hepatitis B patients exhibited a higher frequency of circulating CD4+ CD25 high Treg cells compared to acute hepatitis B patients (P < 0.05), with no significant difference compared to healthy controls.
- CD4+ CD25 high Treg cells expressed high levels of CD45RO, HLA-DR, and CTLA-4, low levels of CD45RA, and specifically expressed FoxP3 mRNA.
- Purified Treg cells demonstrated the ability to suppress the proliferation and IFN-γ secretion of autologous PBMCs, with a more pronounced suppressive effect observed when stimulated with HBV antigen compared to anti-CD3 antibody.
Conclusions:
- Circulating Treg frequency is elevated in CHB patients compared to AHB patients, but similar to healthy individuals.
- FoxP3 mRNA is specifically expressed in the CD4+ CD25+ cell population, confirming their regulatory T cell identity.
- Treg cells possess the capacity to suppress HBV antigen-specific T cell responses in vitro, contributing to the understanding of Treg cells' role in hepatitis B immunopathogenesis.
Objective:
Our aim was to investigate the frequency, phenotype and function of CD4+ CD25 high regulatory T cells (Treg) in patients with acute and chronic hepatitis B (AHB, CHB).
Methods:
Peripheral blood mononuclear cells (PBMCs) from 16 AHB patients at acute phase (week 1 of illness), 72 CHB patients, and 32 health subjects were analyzed for Treg frequency and CD45RO, CD45RA, CD95 and HLA-DR phenotype by flow cytometry. Intracellular expression of cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) was examined by intracellular cytokines staining. Forkhead/winged helix transcription factor (FoxP3) mRNA was detected by a real-time RT-PCR assay. The effects of MACS magnetic beads-purified Treg cells on the proliferation of PBMCs were examined by a [3H]-thymidine incorporation assay. The effect of Treg cells on IFN gamma secretion of autologous PBMCs was examined by ELISA.
Results:
CHB patients presented a higher fraction of circulating CD4+ CD25 high Treg frequency than AHB patients (P < 0.05), but had no significant difference compared with healthy controls. CD4+ CD25 high Treg expressed high levels of CD45RO, HLA-DR and CTLA-4, low level of CD45RA, and expressed FoxP3 mRNA specifically. We also observed that Treg cells could suppress the expansion and IFN gamma secretion of autologous PBMCs when stimulated with HBV antigen or anti-CD3 antibody, and the suppressive effect was stronger when HBV antigen was used as stimulator.
Conclusions:
CHB patients presented a higher fraction of circulating Treg frequency than AHB patients at acute phase, but had no significant difference compared with healthy controls. FoxP3 mRNA was specifically expressed in CD4+ CD25+ cell population. Treg could suppress HBV antigen-specific T cell response in vitro. The study furthers our understanding of Treg's role in immunopathogenesis of hepatitis B.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Hepatitis
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

